Literature DB >> 33245333

Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance.

Brigid M Wilson1,2,3, Yunyun Jiang4, Robin L P Jump2,3,5,6, Roberto A Viau7, Federico Perez2,3,5, Robert A Bonomo8,9, Scott R Evans4.   

Abstract

The complexities of antibiotic resistance mean that successful stewardship must consider both the effectiveness of a given antibiotic and the spectrum of that therapy to minimize imposing further selective pressure. To meet this challenge, we propose the Desirability of Outcome Ranking approach for the Management of Antimicrobial Therapy (DOOR MAT), a flexible quantitative framework that evaluates the desirability of antibiotic selection. Herein, we describe the steps required to implement DOOR MAT and present examples to illustrate how the desirability of treatment selection can be evaluated using resistance information. While treatments and the scoring of treatment selections must be adapted to specific clinical settings, the principle of DOOR MAT remains constant: The most desirable antibiotic choice effectively treats the patient while exerting minimal pressure on future resistance. Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Entities:  

Keywords:  antibiotic stewardship; antimicrobial resistance; methodology

Year:  2021        PMID: 33245333     DOI: 10.1093/cid/ciaa1769

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT) Reveals Improvements in the Treatment of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae in Patients from the Veterans Health Administration.

Authors:  Federico Perez; Roberto Viau Colindres; Brigid M Wilson; Elie Saade; Robin L P Jump; Ritu Banerjee; Robin Patel; Scott R Evans; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

2.  A case-control study of infections caused by Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase-1: Predictors and outcomes.

Authors:  Eduardo Rodríguez-Noriega; Elvira Garza-González; Paola Bocanegra-Ibarias; Beatriz Alejandra Paz-Velarde; Sergio Esparza-Ahumada; Esteban González-Díaz; Héctor R Pérez-Gómez; Rodrigo Escobedo-Sánchez; Gerardo León-Garnica; Rayo Morfín-Otero
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

3.  Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT).

Authors:  Kimberly C Claeys; Teri L Hopkins; Kathryn Schlaffer; Stephanie Hitchcock; Yunyun Jiang; Scott Evans; J Kristie Johnson; Surbhi Leekha
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.